Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04847752

Study of Predictive Factors Related to Prognosis of Patients With Ischemic Stroke Due to Large-artery Atherosclerosis

Sponsor: Tongji Hospital

View on ClinicalTrials.gov

Summary

This is a single-center prospective cohort study of predictive factors related to prognosis of ischemic stroke due to large-artery atherosclerosis. From March 1, 2021 to December 31, 2026, 1000 patients with ischemic stroke due to large-artery atherosclerosis who are admitted to the Department of Neurology or Neurosurgery, Tongji Hospital are going to be recruited. Detailed clinical data in emergency room and in-hospital will be obtained from the medical record reviews, and the National Institutes of Health Stroke Scale (NIHSS) and Modified Rankin Scale (mRS) score will be done by certified neurologists to assess the severity of the disease in acute stage and treatment outcome during the follow-up. All cases will undergo routine blood tests, brain magnetic resonance imaging (MRI) and cerebral vascular examination, such as TCD, CTA, HRMR or DSA. The investigators will analyze the in-hospital factors that could predict the outcome to provide more evidence-based suggestions in the treatment and prognosis of atherosclerotic ischemic cerebrovascular disease.

Official title: A Prospective Observational Cohort Study of Predictive Factors Related to Prognosis of In-hosiptal Patients With Ischemic Stroke Due to Large-artery Atherosclerosis

Key Details

Gender

All

Age Range

Any - 80 Years

Study Type

OBSERVATIONAL

Enrollment

1000

Start Date

2021-03-01

Completion Date

2028-12-31

Last Updated

2024-06-20

Healthy Volunteers

No

Interventions

PROCEDURE

carotid artery stenting

common treatments for carotid artery stenosis

PROCEDURE

carotid endarterectomy

common treatments for carotid artery stenosis

DRUG

Aspirin

the dosage and duration

DRUG

Clopidogrel

the dosage and duration

DRUG

Anticoagulant

the dosage and duration

DRUG

Statin

the dosage and duration

DRUG

PCSK9 inhibitor

the dosage and duration

Locations (1)

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, China